Why some women stay thin without dieting: science investigates
NCT ID NCT07233109
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at women who are naturally very thin (BMI under 17.5) but do not have an eating disorder. Researchers want to understand how their bodies use energy and how their muscles work compared to women of normal weight. The goal is to learn more about this condition, called constitutional thinness, to help design better care programs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 36 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Dec 2025
An estimate. Start dates often move.
- Expected to finish
-
Feb 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 35 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * BMI ≤ 17.5 kg/m2 * 20 kg/m2 ≤ BMI ≤ 25 kg/m2 Exclusion Criteria: * For women with Constitutional thinness : * Women under guardianship or deprived of their liberty by judicial or administrative decision * Women who are pregnant, breastfeeding, or likely to become pregnant * Women who engage in intense physical activity (more than 3 sessions of physical activity per week) * Abnormal levels of IGF-1, estradiol, free T3, cortisol, and leptin * For the MC group specifically: cases of thinness due to a suspected organic cause. This includes Marfan syndrome, identifiable by: personal or family history of degenerative aortic disease (aneurysm, dissection), ligamentous hyperlaxity, arachnodactyly * History or presence of a systemic condition likely to interfere with the physiological and metabolic parameters measured (e.g., diabetes, endocrine or metabolic disease) * Any acute or chronic disease that may influence the results (e.g., infections, tumors, inflammatory diseases) * Medical or surgical history deemed by the investigator to be incompatible with this study (e.g., muscular, neurological, or joint disorders, or contraindications to the application of a magnetic field, etc.) Presence of diabetes, and any other condition limiting the application of either strategy under trial * Use of medications that may interfere with the study results * Cardiovascular conditions (history of cardiovascular and/or neurovascular disease, as well as the presence of cardiovascular and/or neurovascular risk factors other than obesity/overweight, such as: high blood pressure, high cholesterol, diabetes, heart rhythm disorder, known carotid atherosclerosis, thrombophilia) * Surgery within the previous 3 months * Women excluded from another study * Regular tobacco or alcohol consumption * Specific diets likely to impact metabolism, influence biological parameters (FT3, cortisol in particular) or skew results (deficiencies, low calorie intake). This includes vegan, mono, ketogenic, and low-calorie diets, intermittent fasting, or diets requiring specific supplementation that may interfere with the endocrine system. For women Normal-Weighted Women * Women under guardianship or deprived of their liberty by judicial or administrative decision * Women who are pregnant, breastfeeding, or likely to become pregnant. * Women who engage in intense physical activity (more than 3 sessions of physical activity per week) * History or presence of a systemic condition likely to interfere with the physiological and metabolic parameters measured (e.g., diabetes, endocrine or metabolic disorders) * Any acute or chronic disease that may influence the results (e.g., infections, tumors, inflammatory diseases) * Medical or surgical history deemed by the investigator to be incompatible with this study (e.g., muscular, neurological, or joint disorders, or contraindications to the application of a magnetic field, etc.) * Presence of diabetes or any other condition limiting the application of either strategy under investigation * Taking medications that may interfere with the study results * Cardiovascular conditions (history of cardiovascular and/or neurovascular disease, as well as the presence of cardiovascular and/or neurovascular risk factors other than obesity/overweight, such as: high blood pressure, high cholesterol, diabetes, heart rhythm disorder, known carotid atherosclerosis, thrombophilia) * Surgery within the previous 3 months * Women excluded from another study * Regular tobacco or alcohol consumption * Specific diets likely to impact metabolism, influence biological parameters, or skew results (deficiencies, low calorie intake). This includes vegan, mono, ketogenic, and low-calorie diets, intermittent fasting, or diets requiring specific supplementation that may interfere with the endocrine system.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Constitutional thinness are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Laboratoire AME2P, Université Clermont Auvergne
Aubière, 63170, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.